Midazolam HCL

Independent reference data for Midazolam HCL (CAS 59467-96-8), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Intravenous midazolam is indicated for procedural sedation (often in combination with an opioid, such as fentanyl), for pre-op sedation, for the induction of general anesthesia, and for sedation of ventilated patients in critical care units. Oral midazolam is indicated for the short term treatment of moderately severe insomnia in patients who did not adequately react to other hypnotics, and who have persistent trouble in falling asleep. [Wikipedia]Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage.

Synonyms and trade names

MIDAZOLAM HYDROCHLORIDE; Midazolam Hcl; 59467-96-8; Hypnovel; Rocam; Ro 21-3981/003; DTXSID8047846; Midazolam hydrochloride civ; W7TTW573JJ; NSC-751451; SEIZALAM; SHP615; SHP-615; Midazolam hydrochloride preservative free; Ro-213981001; CHEBI:6932

GHS hazard classification

Reported hazard statements	H302 (100%), H336 (100%), H361 (100%), H362 (100%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

H336 (100%): May cause drowsiness or dizziness [Warning Specific target organ toxicity, single exposure; Narcotic effects]

What the public record says

Midazolam HCL · CAS 59467-96-8 · C18H14Cl2FN3. UNII W7TTW573JJ.

Source: PubChem / Wikidata; the batch COA governs where values differ.